Deutsche Bank sets Acadia Pharmaceuticals stock target at $22
Deutsche Bank (ETR:DBKGn) initiated coverage on Acadia Pharmaceuticals (NASDAQ:ACAD) with a Hold rating and a price target of ...
Deutsche Bank sees S&P 500 resilience amid trade tensions
Deutsche Bank (ETR:DBKGn) analysts highlighting the S&P 500's steady performance despite various market challenges. The index has maintained a narrow fluctuation margin of plus or minus 2% over the ...
Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)
Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
Deutsche Bank Keeps Their Hold Rating on Aurubis (0K7F)
Deutsche Bank analyst Bastian Synagowitz maintained a Hold rating on Aurubis (0K7F – Research Report) today and set a price target of €88.00.